Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review

BACKGROUND: The integrase strand transfer inhibitor dolutegravir (DTG) is being introduced into low- and middle-income countries (LMICs) as an alternative to first-line treatment with non-nucleoside reverse transcriptase inhibitors. However, DTG is not yet widely recommended for use in pregnant wome...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Virus Erad
Asıl Yazarlar: Hill, Andrew, Clayden, Polly, Thorne, Claire, Christie, Rachel, Zash, Rebecca
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mediscript Ltd 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892677/
https://ncbi.nlm.nih.gov/pubmed/29682297
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller